Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyemi Kim

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Archiv Der Pharmazie|February 4, 2026
HBE-843, a Novel, Potent, and Selective EGFR Targeting PROTAC for the Treatment of Non-Small-Cell Lung CancerMohammad Hassan Baig, Chang Joong Kim, Nale Sagar Dattatraya, et al.
Journal of Microbiology (Seoul, Korea)|January 6, 2015
Hypermethylation of the interferon regulatory factor 5 promoter in Epstein-Barr virus-associated gastric carcinomaSeung Myung Dong, Hyun Gyu Lee, Sung-Gyu Cho, et al.
Advanced Healthcare Materials|July 8, 2021
Quantitative Photothermal Characterization with Bioprinted 3D Complex Tissue Constructs for Early-Stage Breast Cancer Therapy Using Gold NanorodsKi-Hwan Nam, Chan Bae Jeong, HyeMi Kim, et al.
Oncotarget|October 2, 2015
Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activationHyun Gyu Lee, Hyemi Kim, Eun Jung Kim, et al.
Yonsei Medical Journal|August 11, 2015
Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular CarcinomaSeung Up Kim, Jeon Han Park, Hyon-Suk Kim, et al.
Journal of Microbiology (Seoul, Korea)|March 5, 2013
Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virusByoung-Shik Shim, Jung-Ah Choi, Ho-Hyun Song, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Archiv Der Pharmazie|February 4, 2026
HBE-843, a Novel, Potent, and Selective EGFR Targeting PROTAC for the Treatment of Non-Small-Cell Lung CancerMohammad Hassan Baig, Chang Joong Kim, Nale Sagar Dattatraya, et al.
Journal of Microbiology (Seoul, Korea)|January 6, 2015
Hypermethylation of the interferon regulatory factor 5 promoter in Epstein-Barr virus-associated gastric carcinomaSeung Myung Dong, Hyun Gyu Lee, Sung-Gyu Cho, et al.
Advanced Healthcare Materials|July 8, 2021
Quantitative Photothermal Characterization with Bioprinted 3D Complex Tissue Constructs for Early-Stage Breast Cancer Therapy Using Gold NanorodsKi-Hwan Nam, Chan Bae Jeong, HyeMi Kim, et al.
Oncotarget|October 2, 2015
Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activationHyun Gyu Lee, Hyemi Kim, Eun Jung Kim, et al.
Yonsei Medical Journal|August 11, 2015
Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular CarcinomaSeung Up Kim, Jeon Han Park, Hyon-Suk Kim, et al.
Journal of Microbiology (Seoul, Korea)|March 5, 2013
Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virusByoung-Shik Shim, Jung-Ah Choi, Ho-Hyun Song, et al.
Pageof 5